Tumour microenvironment & Immuno-oncology

Scientists and clinical experts from the University of Liverpool embedded in a global collaborative network, work together to better understand how the tumour microenvironment impacts cancer progression and its response to therapies with the aim to identify novel therapeutic targets and improve cancer patients outcomes.

Tumour Microenvironment

Tumour Microenvironment

Scientists and clinical experts from the University of Liverpool embedded in a global collaborative network, work together to better understand how the tumour microenvironment impacts cancer progression and its response to therapies with the aim to identify novel therapeutic targets and improve cancer patients outcomes.

Immuno-oncology Natural Killer Cell (NK Cell) destroying a cancer cell

Immuno-oncology

A cross-cutting theme within LCRI, underpinned by significant new investments at the University of Liverpool and collaborator sites, is a focus on research on the interplay between the immune system and cancer cells: immuno-oncology, across different cancer types.